Preliminary evaluation of a polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as an intravascular contrast agent for MR angiography

J Magn Reson Imaging. 1997 Jan-Feb;7(1):204-8. doi: 10.1002/jmri.1880070131.

Abstract

A blood-persistent particulate paramagnetic contrast agent has been formulated via size stabilization of manganese-substituted hydroxylapatite by a polyethylene glycol (PEG) bearing a terminal diphosphonate. At high PEG surface densities (35-40 mol%), particles with mean diameter 8 +/- 2 nm were obtained. Relaxivities of autoclaved samples (at 20 MHz proton Lamor frequency) were R1 = 18.7 +/- .8 mM-1 sec-1 and R2 = 22.3 +/- .7 mM-1 sec-1. The formulation persisted in rabbit blood with a biphasic clearance profile. Half-lives (with amplitudes in parenthesis) were 4 +/- 1 minutes (55%), and 49 +/- 3 minutes (45%), respectively, for the two phases. A dose of 40 mumol Mn/kg body weight enhanced the signal from rabbit vasculature for more than 45 minutes on MR angiograms. Thus, PEG-modified MnHA particles may find use as T1 agents for MR angiography.

MeSH terms

  • Animals
  • Contrast Media* / administration & dosage
  • Drug Stability
  • Durapatite / chemistry*
  • Evaluation Studies as Topic
  • Half-Life
  • Hydroxyapatites* / administration & dosage
  • Hydroxyapatites* / chemistry
  • Hydroxyapatites* / pharmacokinetics
  • In Vitro Techniques
  • Injections, Intravenous
  • Magnetic Resonance Angiography / methods*
  • Manganese / chemistry*
  • Particle Size
  • Polyethylene Glycols / chemistry*
  • Polyethylene Glycols / pharmacokinetics
  • Rabbits
  • Surface Properties

Substances

  • Contrast Media
  • Hydroxyapatites
  • Polyethylene Glycols
  • Manganese
  • Durapatite